Fri, October 16, 2020
Thu, October 15, 2020
Wed, October 14, 2020
Tue, October 13, 2020
Mon, October 12, 2020
Sun, October 11, 2020
Fri, October 9, 2020
Thu, October 8, 2020
Wed, October 7, 2020

David Lebovitz Maintained (ASND) at Buy with Increased Target to $194 on, Oct 13th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-194-on-oct-13th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $179 to $194 on, Oct 13th, 2020.

David has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $158 on, Friday, August 28th, 2020

Publication Contributing Sources